Ledger.Open graph →
SEC Form D · Amendment · filed March 18, 2021

Torus Biosystems, Inc

Offering
$3.0M
Sold
$2.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

David Y. Zhang · Cambridge, MADirectorShawn Marcell · Cambridge, MAExec · DirectorPeng Y. Yin · Cambridge, MADirectorDaniel Mafrice · Nashville, TNDirectorDan Schulte · Overland Park, KSExec · DirectorCarl Farrell · Encino, Los Angeles, CADirectorBen Linden · Cambridge, MAExecSteven R. Mitchell · Tulsa, OKExec · DirectorPhil R. Vantrease · Tulsa, OKDirectorChad Dunham · San Diego, CADirectorBen Linden · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗